20 June 2013
Keywords: generex, oral-lyn, non-inferior, insulin, analogs, us-listed, firm
Article | 30 June 2008
US-listed firm Generex Biotechnology presented strong trial data at the Endocrine Society's 90th annual meeting, held in San Francisco, USA,
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 June 2008
19 June 2013
© 2013 thepharmaletter.com